Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC) - Sub-study 3
Clinical trial NCT06926673 · COMPLETED
Trial details
- NCT number
- NCT06926673
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-23
- Primary completion
- 2024-05-02
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.